• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Depression Mobile Health Apps

UK Startup Flow Launches Chatbot Therapist to Combat Depression

by Jasmine Pennic 09/27/2019 Leave a Comment

UK Startup Flow Launches Chatbot Therapist to Combat Depression

- UK startup launches Flow, a chatbot therapist engages users with daily chat conversations and offers self-help techniques, mood tracking, curated videos, meditation, and mental exercises. - Available to download free on iOS, the chatbot therapist is based on the latest psychology and neuroscience research and was developed by clinical psychologists and machine learning experts. - To maximize the chance of recovery, Flow can be used in conjunction with the Flow brain stimulation
Read More

AbleTo Acquires Digital Therapy App Joyable to Strengthen Virtual Behavioral Healthcare

by Fred Pennic 03/06/2019 Leave a Comment

AbleTo, Inc., a provider of virtual behavioral healthcare proven to improve clinical outcomes and lower healthcare costs has acquired Joyable, an app-based digital therapy innovator. The acquisition strengthens AbleTo's high-quality virtual behavioral healthcare with a digital platform that delivers clinically-based therapies supported by coaches to help individuals overcome depression, generalized anxiety, and social anxiety.Founded in 2014, Joyable offers users expert-designed digital
Read More

Pfizer Launches “Moodivator” App to Help Patients Monitor Depression

by HITC Staff 09/14/2016 Leave a Comment

Pfizer Launches "Moodivator" App to Help Patients Monitor Depression

Pfizer has developed a new mobile health app named Moodivator to help motivate to help motivate and encourage the millions of adults who experience depression. An estimated 1 in 15 adults experience at least one major depressive episode in any given year. To help support, encourage and motivate people with depression, the new app is designed to help patients set and achieve manageable goals—in areas from wellness to treatment—and turn those goals into routines. Patients can regularly log your
Read More

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |